APC and colorectal carcinoma: Treatment with ABT-199 while intestinal stem cells are undergoing APC deletion and hence transformation strongly impairs adenoma outgrowth, which suggests that BCL-2 is a potential target for CRC chemoprevention in patients with high risk conditions such as familial adenomatous polyposis [110].